Literature DB >> 10632117

Cerebrospinal fluid interleukin-10 levels in primary central nervous system lymphoma: a possible marker of response to treatment?

A Salmaggi, M Eoli, E Corsini, M Gelati, S Frigerio, A Silvani, A Boiardi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10632117

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  5 in total

1.  IL-10 -1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas.

Authors:  Hema L Ramkumar; De Fen Shen; Jingsheng Tuo; Rita M Braziel; Sarah E Coupland; Justine R Smith; Chi-Chao Chan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-05-25       Impact factor: 3.117

2.  Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).

Authors:  Takashi Sasayama; Satoshi Nakamizo; Masamitsu Nishihara; Atsufumi Kawamura; Hirotomo Tanaka; Katsu Mizukawa; Shigeru Miyake; Masaaki Taniguchi; Kohkichi Hosoda; Eiji Kohmura
Journal:  Neuro Oncol       Date:  2011-12-12       Impact factor: 12.300

Review 3.  Modern cerebrospinal fluid analyses for the diagnosis of diffuse large B-cell lymphoma of the CNS.

Authors:  Alexander Baraniskin; Roland Schroers
Journal:  CNS Oncol       Date:  2014-01

4.  Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma.

Authors:  Yang Song; Wei Zhang; Li Zhang; Wei Wu; Yan Zhang; Xiao Han; Chen Yang; Lu Zhang; Daobin Zhou
Journal:  Sci Rep       Date:  2016-12-07       Impact factor: 4.379

5.  Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review.

Authors:  Anouk van Westrhenen; Lisanne C A Smidt; Tatjana Seute; Stefan Nierkens; Abraham C J Stork; Monique C Minnema; Tom J Snijders
Journal:  Br J Haematol       Date:  2018-05-29       Impact factor: 6.998

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.